| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
12,634 |
11,382 |
$5.87M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
142,121 |
128,603 |
$5.42M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
160,344 |
153,831 |
$5.08M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
160,156 |
153,703 |
$5.08M |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
104,699 |
102,043 |
$3.06M |
| 81513 |
|
23,803 |
22,464 |
$2.12M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
140,281 |
137,026 |
$1.92M |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
33,317 |
32,338 |
$1.75M |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
79,914 |
76,492 |
$1.68M |
| 76830 |
Ultrasound, transvaginal |
26,892 |
25,003 |
$1.52M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
22,592 |
18,282 |
$1.48M |
| 87800 |
|
29,234 |
28,099 |
$1.09M |
| 96127 |
|
63,682 |
59,515 |
$968K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,830 |
14,687 |
$944K |
| 86780 |
|
71,992 |
68,848 |
$830K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25,961 |
24,725 |
$797K |
| 87660 |
|
45,158 |
41,687 |
$766K |
| 87480 |
|
45,172 |
41,702 |
$765K |
| 87510 |
|
44,513 |
41,372 |
$761K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13,025 |
12,695 |
$759K |
| 87481 |
|
23,786 |
22,514 |
$732K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
3,140 |
2,954 |
$720K |
| 76801 |
|
5,492 |
5,046 |
$655K |
| 59025 |
Fetal non-stress test |
13,837 |
9,192 |
$628K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
10,568 |
9,480 |
$594K |
| 86803 |
|
47,235 |
44,875 |
$585K |
| 87653 |
|
18,331 |
17,668 |
$571K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
6,851 |
5,536 |
$569K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
78,266 |
72,509 |
$556K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,087 |
5,452 |
$552K |
| 87340 |
|
54,646 |
52,267 |
$491K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,900 |
7,489 |
$451K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
64,330 |
60,364 |
$435K |
| 76813 |
|
4,855 |
4,578 |
$350K |
| 86762 |
|
27,975 |
26,135 |
$342K |
| 84443 |
Thyroid stimulating hormone (TSH) |
21,608 |
20,669 |
$320K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,626 |
2,496 |
$307K |
| 84702 |
|
27,350 |
19,992 |
$284K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,531 |
2,896 |
$283K |
| 82670 |
|
11,136 |
10,751 |
$281K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,711 |
9,755 |
$272K |
| 88141 |
|
23,202 |
22,109 |
$241K |
| 83001 |
|
14,113 |
13,578 |
$235K |
| 93976 |
|
1,718 |
1,611 |
$210K |
| 84146 |
|
10,903 |
10,452 |
$192K |
| 81025 |
|
35,008 |
32,597 |
$184K |
| 86696 |
|
10,463 |
9,951 |
$180K |
| 76376 |
|
5,425 |
5,110 |
$151K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17,629 |
16,796 |
$149K |
| 87625 |
|
5,007 |
4,931 |
$149K |
| 83002 |
|
8,720 |
8,456 |
$147K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,949 |
4,506 |
$147K |
| 86850 |
|
39,357 |
36,753 |
$129K |
| 84144 |
|
6,585 |
6,021 |
$125K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,444 |
1,292 |
$117K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,355 |
4,169 |
$115K |
| 87015 |
|
18,334 |
17,670 |
$108K |
| 86695 |
|
8,980 |
8,567 |
$106K |
| 82950 |
|
25,026 |
24,121 |
$105K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
41 |
40 |
$100K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,644 |
6,802 |
$95K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,522 |
2,892 |
$93K |
| 86900 |
|
34,541 |
32,275 |
$88K |
| 86901 |
|
34,209 |
32,147 |
$87K |
| 87077 |
|
11,466 |
10,860 |
$83K |
| 87088 |
|
11,408 |
10,831 |
$83K |
| 82627 |
|
4,013 |
3,897 |
$82K |
| 82951 |
|
7,299 |
6,859 |
$81K |
| 86787 |
|
6,844 |
6,386 |
$75K |
| 84439 |
|
9,286 |
8,830 |
$73K |
| 85027 |
|
11,602 |
11,093 |
$67K |
| 88142 |
|
4,443 |
4,345 |
$61K |
| 80053 |
Comprehensive metabolic panel |
5,455 |
5,133 |
$51K |
| 82607 |
|
3,397 |
3,262 |
$46K |
| 80050 |
General health panel |
1,291 |
1,259 |
$46K |
| 99385 |
|
738 |
715 |
$45K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,873 |
1,396 |
$37K |
| 99459 |
|
2,693 |
2,609 |
$33K |
| 82728 |
|
2,563 |
2,470 |
$32K |
| 82746 |
|
2,229 |
2,157 |
$30K |
| 80061 |
Lipid panel |
2,455 |
2,370 |
$30K |
| 59514 |
|
51 |
49 |
$27K |
| 83525 |
|
2,568 |
2,464 |
$27K |
| 87147 |
|
5,471 |
5,263 |
$26K |
| 82952 |
|
5,847 |
5,623 |
$20K |
| 87186 |
|
2,316 |
2,193 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
169 |
156 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
848 |
770 |
$16K |
| 84703 |
|
2,350 |
2,267 |
$16K |
| 93975 |
|
105 |
103 |
$16K |
| 86304 |
|
841 |
818 |
$16K |
| 80076 |
|
1,932 |
1,793 |
$14K |
| 88344 |
|
198 |
157 |
$14K |
| 99215 |
Prolong outpt/office vis |
188 |
176 |
$14K |
| 99234 |
|
174 |
166 |
$13K |
| 99404 |
|
157 |
110 |
$10K |
| 82947 |
|
2,830 |
2,696 |
$10K |
| 87210 |
|
1,709 |
1,565 |
$9K |
| 76857 |
|
184 |
176 |
$8K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
140 |
105 |
$8K |
| 84550 |
|
3,455 |
3,153 |
$7K |
| 90651 |
|
29 |
28 |
$7K |
| 80305 |
|
976 |
915 |
$7K |
| 97810 |
|
581 |
204 |
$6K |
| 81002 |
|
57,159 |
54,080 |
$5K |
| 84450 |
|
3,083 |
2,819 |
$5K |
| 36416 |
|
1,719 |
1,622 |
$5K |
| 90686 |
|
343 |
281 |
$5K |
| 82565 |
|
2,526 |
2,333 |
$5K |
| 82272 |
|
1,633 |
1,566 |
$5K |
| 84460 |
|
3,094 |
2,827 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,420 |
1,263 |
$4K |
| 82270 |
|
1,467 |
1,412 |
$4K |
| 90674 |
|
197 |
181 |
$4K |
| 83986 |
|
1,458 |
1,354 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
513 |
500 |
$4K |
| 82120 |
|
1,322 |
1,224 |
$4K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,348 |
1,340 |
$4K |
| 76641 |
|
45 |
40 |
$3K |
| 76818 |
|
31 |
28 |
$3K |
| 88307 |
|
51 |
37 |
$3K |
| 83615 |
|
1,325 |
1,207 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
569 |
521 |
$3K |
| 87184 |
|
421 |
407 |
$3K |
| 84520 |
|
2,113 |
1,954 |
$3K |
| 99235 |
|
25 |
24 |
$3K |
| 85018 |
|
2,366 |
2,251 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
45 |
43 |
$2K |
| 88112 |
|
26 |
24 |
$2K |
| 90656 |
|
112 |
93 |
$2K |
| 99442 |
|
30 |
29 |
$1K |
| 81003 |
|
3,395 |
2,320 |
$682.33 |
| 54150 |
|
14 |
13 |
$626.40 |
| 58300 |
|
14 |
14 |
$592.41 |
| 96040 |
|
15 |
15 |
$344.25 |
| 90688 |
|
22 |
20 |
$338.96 |
| 51798 |
|
43 |
39 |
$249.42 |
| 88304 |
|
15 |
12 |
$164.23 |
| 82274 |
|
12 |
12 |
$149.64 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
50 |
41 |
$101.10 |
| 82248 |
|
40 |
37 |
$91.67 |
| 81000 |
|
41 |
37 |
$87.04 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
25 |
24 |
$48.42 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
31 |
26 |
$5.38 |
| 7025F |
|
860 |
854 |
$0.00 |
| A4550 |
Surgical trays |
29 |
29 |
$0.00 |
| 0502F |
|
16 |
16 |
$0.00 |